Stay up to date...

QUESTIONS ON NOTICE

Questions are currently being updated, please check back soon for previous questions.

Does the policy on workplace conduct apply to former Justices of the High Court of Australia? Does the High Court of Australia currently provide offices to former Justices of the High Court of Australia? Has it provided offices to former Justices of the High Court of Australia in the recent past (the last five years) ? Which former Justices of the High Court of Australia have been provided offices or access to offices? What period (start and finish date) were they provided access? Has there been a complaint of inappropriate workplace conduct against any former Justices of the High Court of Australia in relation to their behavior in office facilities provided by the High Court of Australia? What was the alleged conduct that was complained of? Was there an investigation into the alleged conduct? What were its findings? Was access to offices by any former Justices of the High Court of Australia revoked as a result of a complaint? When? Why? When does the Attorney-General expect to set up the Federal Judicial Commission? Is there a register of interests for Justices of the High Court of Australia, similar to the register for politicians? If not, why not? How can people feel confident they are getting a fair trial if Justices of the High Court of Australia are not fully transparent as to their interests?

ASIC held a forum which occurred last week on 3-4 November 2022. I note that ticket prices for the forum this year was more than $AUD 2,000 per ticket. 1. Do you think it is appropriate that ASIC is giving access to the big end of town to its senior leadership at a price point which is inaccessible to mum and dad retail investors? Does ASIC concede that mum and dad retail investors who may wish want to engage with ASIC’s executive leadership don’t have $AUD 2,000 to spend on a ticket? 2. Are events such as the ASIC Forum opportunities for ASIC’s senior leadership to be captured by the big end of town? 3. Can ASIC confirm whether anyone from the Office of Enforcement attended the ASIC Forum? If so, is it appropriate that ASIC’s law enforcement staff attend an expensive event with people that they may investigate at some point in the future?

On 28 October 2022, ASIC issued a press release stating that ASIC found a material deterioration of audit quality in the past 12 months (https://asic.gov.au/about-asic/newscentre/find-a-media-release/2022-releases/22-296mr-asic-reports-on-audit-inspectionfindings-for-12-months-to-30-june-2022/). Has ASIC considered whether companies are engaging and remunerating auditors appropriately given the size and scope of the company? For example, does ASIC consider ratios such as audit fees as a percentage of revenue to determine whether the external auditor has been appropriately engaged to perform a proper and comprehensive audit?

1. When ASIC decides to commence an official investigation on a corporate entity or individual persons who within ASIC becomes aware of the investigation and the company and/or people who are the target of that investigation? 2. Are ASIC staff outside the Office of Enforcement able to find out who is being officially investigated by ASIC? 3. Does ASIC ever inform the Department of the Treasury about active official investigations and who are the subject of them? 4. Does ASIC ever inform the Treasurer, the Assistant Treasurer, or any other Cabinet Minister about what official investigations are being undertaking by ASIC and who are subject of those investigations? If so, when does ASIC make these disclosures and how does ASIC exercise its discretion? 5. Is the Treasurer or the Assistant Treasurer able to ask ASIC who is under official investigation? If so, what are the procedures of how such requests are made and managed? 6. If ASIC becomes aware that a Federal Parliamentarian has either a public or private relationship with a corporate entity or individuals under official investigation, what does ASIC do in this circumstance? Are there any operational procedures? Does ASIC’s operational procedures in this regard change if the Federal Parliamentarian is a Cabinet Minister? 7. Under section 14 of the ASIC Act, the Treasurer has the legal power to instruct ASIC to commence an investigation. Conversely, does the Treasurer (or other Cabinet Minister such as the Prime Minister) have the power to instruct ASIC to shut down an official investigation? If so, where is this legal power and how would the Treasurer exercise this power? 8. Who within ASIC has the operational power to close an official investigation? Is it: a. The senior investigator? b. The senior manager? c. The executive leaders within the Office of Enforcement? d. ASIC’s Enforcement Committee (which includes ASIC’s Deputy Chair)? e. The ASIC Chairman? 9. Has a Federal Parliament ever been subjected to a section 19 examination by ASIC? On how many occasions has this occurred?

Senator RENNICK: Thanks. I thought you guys might have a better understanding, given that you are tech heads who sit there and crunch the numbers. That is good to know. I have one other question. In that breakout last year, there was a big jump in various causes. I did put in a request to the ABS if I could get a breakout of non-specific causes that weren’t listed line by line. Would it be possible to get a breakout of non-specific causes line by line in greater detail? Dr Gruen: We can take that on notice

Senator RENNICK: Did you track how many people are out of work because of the vaccine mandates? In your job numbers, are you tracking how many people are out of work because of vaccine mandates? Dr Gruen: We ask people a range of questions in the labour force survey. Again, I think it’s probably best to pass to Mr Jarvis. Mr Jarvis: We do track across a range of labour market measures people going in and out of employment. We ask questions that focus on a range of reasons, but we don’t ask questions that specifically go to that as a factor. Senator RENNICK: Do I ask you to do that? We have significant labour shortages in this country. I think it is important that people in the government find out at least how much willing but idle labour is sitting there because of those mandates. Is that something you can do? Dr Gruen: We can take that on notice.

45. Why do people have to lodge a FOI to get serious adverse event data from the TGA – shouldn’t it be made available with weekly reports? I refer to FOI-3520 that had to be lodged in order to get the total number of serious adverse events following Covid-19 vaccine injections? 46. Can the TGA point out where on the weekly reports are the total of serious adverse events listed as per John Skerritts comments in estimates that they are listed? There is nowhere that specifically states how many of the total adverse events reported are serious.

115. There are fifty adverse event reports in children under 17 years old for Moderna Spikevax (100 ug of mRNA) and roughly the same amount in the 5 to 11 year old group where an adult dose of 30 ug was given instead of the provisionally authorised 10 ug all since January 10 – Feb 3. That’s roughly 100 children incorrectly given a much stronger dose and unauthorised for their age. What is the TGA doing about the administrators of vaccines giving wrong dosage amounts to children. I note Phase I dose finding studies halted the 30 ug dose in the sentinel group after a safety committee deemed it too unsafe to continue in that dose for that age group? 217. Why did ATAGI approve the Pfizer vaccine for children given it wasn’t powered to detect rare adverse events? 218. How can ATAGI guarantee that there will no long-term adverse events in children if no long-term testing was carried out on the vaccine? 219. How can ATAGI guarantee that there will no long-term adverse events in children if no long-term testing was carried out on the vaccine? 220. There have already been reports of severe adverse events in children aged 5-11 that weren’t detected in the initial children’s trials including strokes, tardive dyskinesia, chest pain, myocarditis and pericarditis. Given the large number and the broad range of adverse events will ATAGI withdraw its recommendation that the vaccine be rolled out to children?

128. Has the TGA assessed the risk of, and presence of micro-RNA sequences comprised within the Pfizer vaccine? 129. Has the TGA assessed the risk of and or presence of Stop Codon read- through arising as a result of the use pseudouridine in the Pfizer miRNA active ingredient? 130. Do the mRNA strands have stop codons embedded in them? If not, how will the cell stop producing spike proteins? 131. Has the TGA tested the quality of the mRNA strands in the vaccine to determine how many are mal-coded or damaged for every given inoculation? 132. Can the TGA guarantee that no other protein is transcribed by the mRNA vaccine other the purported Covid-19 spike protein? If not why not? 133. How many mRNA strands are in one dose of the Pfizer vaccine? 134. How can Pfizer/TGA guarantee that each does of the Pfizer vaccine will have the same number of mRNA strands?

Senator RENNICK: Okay; that’s fine. When you review that data, can you please tell me how many people in the placebo trial were hospitalised, how many in the inoculation trial were hospitalised and how many died in the initial Pfizer trial?Dr Skerritt: Senator, we’ll put the data on deaths in the placebo and active arm as an answer to a question on notice.Senator RENNICK: I know the answer to that now; it’s actually zero and zero, because the initial Pfizer trial had no clinical outcomes in terms of hospitalisations and death and it had no-Dr Skerritt: Senator, I do not believe that is correct.Senator RENNICK: In the initial Pfizer trial, in the six-month data, there are different numbers, but-Dr Skerritt: Senator, I do not believe that you are correct-Senator RENNICK: Okay. We can move on.Dr Skerritt: I’m happy to, on notice. I do not believe that the Pfizer trial for the COVID-19 vaccine lacked data on hospitalisations. I do not believe that your assertion is correct.Senator RENNICK: Okay. I did not say it lacked data; I asked how many went to hospital. I’m asking you how many went to hospital and how many died in the inoculation group and the placebo group.Dr Skerritt: We will provide that information on notice.Senator RENNICK: Could you also provide subclinical outcomes regarding clotting and inflammation.Dr Skerritt: We’ll provide that additional information from the trial data, on notice.Senator RENNICK: Yes, on the initial trial data and not the six-month trial data.Dr Skerritt: Yes, on the initial. As long as-Senator RENNICK: Okay. Thanks, Chair.

Does the policy on workplace conduct apply to former Justices of the High Court of Australia? Does the High Court of Australia currently provide offices to former Justices of the High Court of Australia? Has it provided offices to former Justices of the High Court of Australia in the recent past (the last five years) ? Which former Justices of the High Court of Australia have been provided offices or access to offices? What period (start and finish date) were they provided access? Has there been a complaint of inappropriate workplace conduct against any former Justices of the High Court of Australia in relation to their behavior in office facilities provided by the High Court of Australia? What was the alleged conduct that was complained of? Was there an investigation into the alleged conduct? What were its findings? Was access to offices by any former Justices of the High Court of Australia revoked as a result of a complaint? When? Why? When does the Attorney-General expect to set up the Federal Judicial Commission? Is there a register of interests for Justices of the High Court of Australia, similar to the register for politicians? If not, why not? How can people feel confident they are getting a fair trial if Justices of the High Court of Australia are not fully transparent as to their interests?

ASIC held a forum which occurred last week on 3-4 November 2022. I note that ticket prices for the forum this year was more than $AUD 2,000 per ticket. 1. Do you think it is appropriate that ASIC is giving access to the big end of town to its senior leadership at a price point which is inaccessible to mum and dad retail investors? Does ASIC concede that mum and dad retail investors who may wish want to engage with ASIC’s executive leadership don’t have $AUD 2,000 to spend on a ticket? 2. Are events such as the ASIC Forum opportunities for ASIC’s senior leadership to be captured by the big end of town? 3. Can ASIC confirm whether anyone from the Office of Enforcement attended the ASIC Forum? If so, is it appropriate that ASIC’s law enforcement staff attend an expensive event with people that they may investigate at some point in the future?

On 28 October 2022, ASIC issued a press release stating that ASIC found a material deterioration of audit quality in the past 12 months (https://asic.gov.au/about-asic/newscentre/find-a-media-release/2022-releases/22-296mr-asic-reports-on-audit-inspectionfindings-for-12-months-to-30-june-2022/). Has ASIC considered whether companies are engaging and remunerating auditors appropriately given the size and scope of the company? For example, does ASIC consider ratios such as audit fees as a percentage of revenue to determine whether the external auditor has been appropriately engaged to perform a proper and comprehensive audit?

1. When ASIC decides to commence an official investigation on a corporate entity or individual persons who within ASIC becomes aware of the investigation and the company and/or people who are the target of that investigation? 2. Are ASIC staff outside the Office of Enforcement able to find out who is being officially investigated by ASIC? 3. Does ASIC ever inform the Department of the Treasury about active official investigations and who are the subject of them? 4. Does ASIC ever inform the Treasurer, the Assistant Treasurer, or any other Cabinet Minister about what official investigations are being undertaking by ASIC and who are subject of those investigations? If so, when does ASIC make these disclosures and how does ASIC exercise its discretion? 5. Is the Treasurer or the Assistant Treasurer able to ask ASIC who is under official investigation? If so, what are the procedures of how such requests are made and managed? 6. If ASIC becomes aware that a Federal Parliamentarian has either a public or private relationship with a corporate entity or individuals under official investigation, what does ASIC do in this circumstance? Are there any operational procedures? Does ASIC’s operational procedures in this regard change if the Federal Parliamentarian is a Cabinet Minister? 7. Under section 14 of the ASIC Act, the Treasurer has the legal power to instruct ASIC to commence an investigation. Conversely, does the Treasurer (or other Cabinet Minister such as the Prime Minister) have the power to instruct ASIC to shut down an official investigation? If so, where is this legal power and how would the Treasurer exercise this power? 8. Who within ASIC has the operational power to close an official investigation? Is it: a. The senior investigator? b. The senior manager? c. The executive leaders within the Office of Enforcement? d. ASIC’s Enforcement Committee (which includes ASIC’s Deputy Chair)? e. The ASIC Chairman? 9. Has a Federal Parliament ever been subjected to a section 19 examination by ASIC? On how many occasions has this occurred?

Senator RENNICK: Thanks. I thought you guys might have a better understanding, given that you are tech heads who sit there and crunch the numbers. That is good to know. I have one other question. In that breakout last year, there was a big jump in various causes. I did put in a request to the ABS if I could get a breakout of non-specific causes that weren’t listed line by line. Would it be possible to get a breakout of non-specific causes line by line in greater detail? Dr Gruen: We can take that on notice

Senator RENNICK: Did you track how many people are out of work because of the vaccine mandates? In your job numbers, are you tracking how many people are out of work because of vaccine mandates? Dr Gruen: We ask people a range of questions in the labour force survey. Again, I think it’s probably best to pass to Mr Jarvis. Mr Jarvis: We do track across a range of labour market measures people going in and out of employment. We ask questions that focus on a range of reasons, but we don’t ask questions that specifically go to that as a factor. Senator RENNICK: Do I ask you to do that? We have significant labour shortages in this country. I think it is important that people in the government find out at least how much willing but idle labour is sitting there because of those mandates. Is that something you can do? Dr Gruen: We can take that on notice.

45. Why do people have to lodge a FOI to get serious adverse event data from the TGA – shouldn’t it be made available with weekly reports? I refer to FOI-3520 that had to be lodged in order to get the total number of serious adverse events following Covid-19 vaccine injections? 46. Can the TGA point out where on the weekly reports are the total of serious adverse events listed as per John Skerritts comments in estimates that they are listed? There is nowhere that specifically states how many of the total adverse events reported are serious.

115. There are fifty adverse event reports in children under 17 years old for Moderna Spikevax (100 ug of mRNA) and roughly the same amount in the 5 to 11 year old group where an adult dose of 30 ug was given instead of the provisionally authorised 10 ug all since January 10 – Feb 3. That’s roughly 100 children incorrectly given a much stronger dose and unauthorised for their age. What is the TGA doing about the administrators of vaccines giving wrong dosage amounts to children. I note Phase I dose finding studies halted the 30 ug dose in the sentinel group after a safety committee deemed it too unsafe to continue in that dose for that age group? 217. Why did ATAGI approve the Pfizer vaccine for children given it wasn’t powered to detect rare adverse events? 218. How can ATAGI guarantee that there will no long-term adverse events in children if no long-term testing was carried out on the vaccine? 219. How can ATAGI guarantee that there will no long-term adverse events in children if no long-term testing was carried out on the vaccine? 220. There have already been reports of severe adverse events in children aged 5-11 that weren’t detected in the initial children’s trials including strokes, tardive dyskinesia, chest pain, myocarditis and pericarditis. Given the large number and the broad range of adverse events will ATAGI withdraw its recommendation that the vaccine be rolled out to children?

128. Has the TGA assessed the risk of, and presence of micro-RNA sequences comprised within the Pfizer vaccine? 129. Has the TGA assessed the risk of and or presence of Stop Codon read- through arising as a result of the use pseudouridine in the Pfizer miRNA active ingredient? 130. Do the mRNA strands have stop codons embedded in them? If not, how will the cell stop producing spike proteins? 131. Has the TGA tested the quality of the mRNA strands in the vaccine to determine how many are mal-coded or damaged for every given inoculation? 132. Can the TGA guarantee that no other protein is transcribed by the mRNA vaccine other the purported Covid-19 spike protein? If not why not? 133. How many mRNA strands are in one dose of the Pfizer vaccine? 134. How can Pfizer/TGA guarantee that each does of the Pfizer vaccine will have the same number of mRNA strands?

Senator RENNICK: Okay; that’s fine. When you review that data, can you please tell me how many people in the placebo trial were hospitalised, how many in the inoculation trial were hospitalised and how many died in the initial Pfizer trial?Dr Skerritt: Senator, we’ll put the data on deaths in the placebo and active arm as an answer to a question on notice.Senator RENNICK: I know the answer to that now; it’s actually zero and zero, because the initial Pfizer trial had no clinical outcomes in terms of hospitalisations and death and it had no-Dr Skerritt: Senator, I do not believe that is correct.Senator RENNICK: In the initial Pfizer trial, in the six-month data, there are different numbers, but-Dr Skerritt: Senator, I do not believe that you are correct-Senator RENNICK: Okay. We can move on.Dr Skerritt: I’m happy to, on notice. I do not believe that the Pfizer trial for the COVID-19 vaccine lacked data on hospitalisations. I do not believe that your assertion is correct.Senator RENNICK: Okay. I did not say it lacked data; I asked how many went to hospital. I’m asking you how many went to hospital and how many died in the inoculation group and the placebo group.Dr Skerritt: We will provide that information on notice.Senator RENNICK: Could you also provide subclinical outcomes regarding clotting and inflammation.Dr Skerritt: We’ll provide that additional information from the trial data, on notice.Senator RENNICK: Yes, on the initial trial data and not the six-month trial data.Dr Skerritt: Yes, on the initial. As long as-Senator RENNICK: Okay. Thanks, Chair.

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard